Replies to post #4369 on Kasten Inc. (KAST)

[PhenixBleu]

As clearly annotated in each of the 2017 quarterly reports, the financials have been stated without fully merged and comprehensive legacy numbers from the DAKOTA Life Sciences merger. When completed, these numbers will reflect the extensive financial details related to years of pharmaceutical research and development by DAKOTA. It has been the Company goal to provide fully merged GAAP financials as the basis for our Annual Report, due for filing soon. Due to the lack of new capital formation in 2017, the accounting effort to achieve these fully merged comprehensive financials was delayed. Regardless, the rapid completion of a PCAOB audit, in a form suitable for possible up-listing of the stock in 2018, is well underway.

Kasten, Inc.
Consolidated Financial Statement
September 30, 2017
Amended February 27, 2018
KASTEN, INC
STATEMENTS OF EARNINGS
(Unaudited and without full integration of merger financials pending H2 PCAOB audit

Links to filings, news, website are at top of iBox.

Dakota has no financials on their website to reference.